Australia's Prana shares jump 26 pct after drug trial success

SYDNEY Tue Feb 18, 2014 6:20pm EST

Related Topics

SYDNEY Feb 19 (Reuters) - Australia's Prana Biotechnology Ltd shares jumped as much as 26 percent on Wednesday, after the company said its experimental brain disorder drug improved cognitive function in a study on patients with Huntington's disease.

Prana shares last traded up 24.6 percent at A$1.14 at 2312 GMT. (Reporting by Maggie Lu Yueyang)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.